Media & Press Releases

Chugai Pharmaceutical Co., Ltd. is advancing pharmaceutical manufacturing through extensive automation at its FJ3 active pharmaceutical ingredient (API) production facility, a project that was recently recognized with a 2026 ISPE Facility of the Year...

Sanofi’s effort to replicate its pioneering “ballroom” biomanufacturing design across two continents has become a standout example of how global standardization can accelerate capacity, flexibility, and regulatory alignment in modern biologics...

AstraZeneca’s fully electrified Cell Therapy Facility in Rockville, Maryland represents a major leap in sustainable, resilient, and patient‑centric manufacturing. As described in the article that follows from Cell & Gene, the site was engineered to...

The 2026 ISPE Annual Meeting & Expo will take place from 18–21 October in Washington, D.C., USA, and virtually. ISPE has announced Jose Caraballo-Oramas, Executive Chair, Founder, and Principal, JCO Global Advisory LLC, as the Executive Chair of the...

Best practices from AI and cloud integration to data integrity and cybersecurity Since the COVID-19 pandemic, the life sciences industry has seen a push to bring system validation onto a single, computerized system that manages validation, design and...

North Bethesda, Maryland – 7 July 2026 – The International Society for Pharmaceutical Engineering (ISPE) today announced the establishment of the Greece and Cyprus Affiliate, further expanding ISPE’s global network of more than 40 Affiliates and...

At the 2026 ISPE Europe Annual Conference, Scott Slavens, IT Director, Eli Lilly and Company, along with Gilad Langer, Industry Practice Lead, Tulip, presented a session, “Operational Excellence Through Connected Frontlines: A Case Study in Pharma...

During the 2026 ISPE Europe Annual Conference, ISPE announced the 2026 FOYA Category Winners. The article that follows shares an overview of this year’s winners, including the project companies, names, and their locations. The 2026 FOYA Category...

Sanofi’s Canadian operations are undergoing a major transformation as the global biopharmaceutical company deepens its commitment to environmental sustainability, community engagement, and greener manufacturing practices. This article highlights how...

During the 2026 ISPE Europe Annual Conference, Syed Abbas Yar‑Khan, Group Vice President, Global Parenteral Products and Devices, Eli Lilly and Company, presented a keynote speech entitled, “Stronger Together: A One Team Mindset to Building a Global...